Skip to main content Skip to navigation

News


Select tags to filter on

Cell-Freezing Market to be transformed by University of Warwick Spin-Out CryoLogyx

The University of Warwick spin-out company, CryoLogyx, has been awarded £300k from InnovateUK to develop innovate cryopreservation agents with applications in the diagnostic, medicines discovery and cell-based therapy markets.

For commercial enquiries contact Dr James Lapworth, Warwick Innovations, email: j.lapworth@warwick.ac.uk, tel: + 44 (0)2476 575481

Thu 11 Feb 2021, 11:55 | Tags: Life Sciences and Biotechnology, Warwick Innovations

Warwick patented technology in new biomaterials for medical applications

Researchers in the UK and the United States have succeeded in ‘fine tuning’ a new thermoplastic biomaterial to enable both the rate at which it degrades in the body and its mechanical properties to be controlled independently.

For commercial enquiries contact Dr James Lapworth, Warwick Innovations, email: j.lapworth@warwick.ac.uk, tel: + 44 (0)2476 575481

Wed 20 Jan 2021, 14:10 | Tags: Life Sciences and Biotechnology, medical

NanoSyrinx strengthens board with appointment of Dr Jane Dancer as Non-Executive Director

NanoSyrinx announces the appointment of Dr Jane Dancer to its Board as Non-Executive Director.

Thu 10 Dec 2020, 15:03 | Tags: Life Sciences and Biotechnology, spinout

Social Sciences: Opportunity for ambitious early career and PhD researchers – Venture Into Business Engagement (VIBE)

VIBE has been designed to complement and enhance your research journey. Over the course of five sessions starting November 3rd, the programme aims to boost both your personal development and the real-world impact of your research. The facilitators have worked tirelessly to ensure that COVID-19 will not stop participants from getting the most engaging and communal experience possible and have designed a fully immersive and collaborative digital workshop.

Find out more here

Application form here

Thu 01 Oct 2020, 09:26 | Tags: Social Sciences, VIBE, Arts

NanoSyrinx secures capital to develop its customisable platform for intra-cellular engineering

NanoSyrinx, an emerging biotechnology company developing new therapeutic modalities for Cell & Gene editing, announced the closing of a Pre-Seed financing led by M Ventures, the corporate venture capital arm of Merck. BioCity (Nottingham, United Kingdom) and UK Innovation & Science Seed Fund also participated in the financing.

Wed 30 Sep 2020, 10:24 | Tags: Life Sciences and Biotechnology

Diagnostic tool for Coronavirus being developed by University of Warwick makes significant step forward

New study published on rapid test for Coronavirus being developed by University of Warwick demonstrates detection using a model virus rather than just proteins. The diagnostic tool will function without any need for training or complex infrastructure, looking like a ‘pregnancy test’. The team are seeking philanthropic or investment partners to develop and take forward this new technology

Mon 28 Sep 2020, 09:48 | Tags: Warwick Ventures, Life Sciences and Biotechnology, medical

Universities of Birmingham and Warwick form spinout company, 4D Medicine Ltd, to take new family of biomedical 3D printing resins to market

The Universities of Birmingham and Warwick have created a new spinout company, 4D Medicine Ltd, to commercialise a new class of materials – liquid resins that can be printed into solid 3D scaffolds to help patients recover from major medical procedures more quickly.

Mon 20 Jul 2020, 14:25 | Tags: Life Sciences and Biotechnology, investors

Warwick researchers bid to revolutionise coronavirus testing features on BBC News

The work being done at University of Warwick, in collaboration with Iceni Diagnostics, around developing a new approach to rapid coronavirus diagnostics has been featured on the BBC. On Thursday 25 June, BBC Midlands interviewed Professor Gibson and members of his team - a feature on this can be read on the BBC News web pages. You can also see the news report video here.


New diagnostic tool for rapid detection of Coronavirus being developed by University of Warwick and Partners

Coronavirus diagnostics currently require centralised facilities and collection/distribution of swabs and results are ‘next day’. A new diagnostic tool being developed by the University of Warwick and its partner Iceni Diagnostics may allow on-the-spot detection of Coronavirus infection, without facilities using a simple disposal device.

Tue 16 Jun 2020, 15:13 | Tags: Life Sciences and Biotechnology, medical

Warwick Ventures Spin-out Sarissa Biomedical Secures £1.2million Investment

University of Warwick spin-out Sarissa Biomedical raises £1.2m for new test to diagnose stroke victims

Mon 01 Jun 2020, 12:08

Older news